Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical and Experimental Allergy

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2222.1998.00216.xPMID 9515599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE EOSINOPHILIC LEUKOCYTE

  2003cited by this paper
• Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity.

  1997cited by this paper
• High levels of eosinophil cationic protein in wheezing infants predict the development of asthma.

  1997cited by this paper
• Relationship between disease severity and inflammatory markers in cystic fibrosis.

  1996cited by this paper
• Early pulmonary inflammation in infants with cystic fibrosis.

  1995cited by this paper
• Effect of high-dose ibuprofen in patients with cystic fibrosis.

  1995cited by this paper
• The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections

  1995cited by this paper
• Clinical value of monitoring eosinophil activity in asthma.

  1995cited by this paper
• A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.

  1995cited by this paper
• Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis.

  1995cited by this paper
• Eosinophilic activation in cystic fibrosis.

  1994cited by this paper
• Clinical experience with the measurement of ECP: usefulness in the management of children with asthma

  1993cited by this paper
• Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season.

  1992cited by this paper
• T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis.

  1992cited by this paper
• Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo

  1991cited by this paper
• Human eosinophils are more toxic than neutrophils in antibody-independent killing.

  1991cited by this paper
• Secretion of granule proteins from eosinophils and neutrophils is increased in asthma.

  1991cited by this paper
• Inflammation in the lung in cystic fibrosis

  1991cited by this paper
• The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity.

  1988cited by this paper
• Lung Function in Children and Adolescents: Methods, reference values

  1987cited by this paper
• Hypergammaglobulinemia in cystic fibrosis. Role of Pseudomonas endobronchial infection.

  1987cited by this paper
• The eosinophilic leukocyte: structure and function.

  1986cited by this paper
• Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

  1984cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis.

  1984cited by this paper
• Summary of a workshop on infections in patients with cystic fibrosis.

  1979cited by this paper
• The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups.

  1976cited by this paper
• Long-Term Study of 105 Patients with Cystic Fibrosis

  1958cited by this paper
• Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

  1958cited by this paper

• Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities.

  2021cites this paper
• Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk

  2021cites this paper
• Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis

  2020cites this paper
• Galectins, Eosinophiles, and Macrophages May Contribute to Schistosoma japonicum Egg-Induced Immunopathology in a Mouse Model

  2020cites this paper
• Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis

  2018cites this paper
• The Role Of Thiocyanate In Modulating Tissue Damage In Cardiovascular Disease

  2017cites this paper
• Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis

  2016cites this paper
• Association Between Serum ECP levels and FEV 1 in Asthma

  2016cites this paper
• Efficacy and adverse effects of drugs used to treat adult cystic fibrosis

  2015cites this paper
• An Extragranular Compartment of Blood Eosinophils Contains Eosinophil Protein X/Eosinophil-Derived Neurotoxin (EPX/EDN)

  2012cites this paper
• Hypothiocyanous acid: benign or deadly?

  2012cites this paper
• Reactions and reactivity of myeloperoxidase-derived oxidants: Differential biological effects of hypochlorous and hypothiocyanous acids

  2012cites this paper
• Eosinophil cationic protein--current concepts and controversies.

  2011cites this paper
• Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.

  2010cites this paper
• [The role of leukotrienes in inflammatory process in cystic fibrosis].

  2008cites this paper
• Mammalian Heme Peroxidases: From Molecular Mechanisms to Health Implications

  2008influential citation
• [Serum and sputum eosinophil cationic protein levels and clinical status in cystic fibrosis patients].

  2006cites this paper
• Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis.

  2005cites this paper
• [Effect of montelukast on lung function and clinical symptoms in patients with cystic fibrosis].

  2004cites this paper
• Monitoring the allergic inflammation

  2004cites this paper
• Correlation of eosinophil cationic protein with severity of asthma.

  2004cites this paper
• Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis

  2003cites this paper
• Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.

  2002cites this paper
• Diagnostik der cystischen Fibrose

  2001cites this paper
• Higher Serum Eosinophil Cationic Protein Levels in Children with Cow's Milk Allergy

  2001cites this paper
• The relationship of eosinophil granule proteins to ions in the sputum of patients with cystic fibrosis

  2000cites this paper
• Surrogate markers of airway inflammation: inflammometry in paediatric respiratory medicine

  2000cites this paper
• Surrogate markers of airway inflammation: inflammometry in paediatric respiratory medicine.

  2000cites this paper
• Inflammatory markers in clinical practice.

  2000cites this paper
• Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis.

  1999cites this paper
• Serum measurement of eosinophil cationic protein in the management of asthma.

  1999cites this paper
• Major basic protein, but not eosinophil cationic protein or eosinophil protein X, is related to atopy in cystic fibrosis

  1999cites this paper
• The practical application and interpretation of simple lung function tests in cystic fibrosis

  1999cites this paper